Spinal cord injury (SCI) is a devastating condition producing great personal and societal costs and for which there is no effective treatment. Stem cell transplantation is a promising therapeutic strategy, though much preclinical and clinical research work remains. Here, we briefly describe SCI epidemiology, pathophysiology, and experimental and clinical stem cell strategies. Research in stem cell biology and cell reprogramming is rapidly advancing, with the hope of moving stem cell therapy closer to helping people with SCI. We examine issues important for clinical translation and provide a commentary on recent developments, including termination of the first human embryonic stem cell transplantation trial in human SCI.
Andrea J. Mothe, Charles H. Tator
Title and authors | Publication | Year |
---|---|---|
Rewiring the spinal cord: Direct and indirect strategies
MT DellAnno, SM Strittmatter |
Neuroscience Letters | 2016 |
The nanomaterial toolkit for neuroengineering
S Shah |
Nano Convergence | 2016 |
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury
V Doulames, G Plant |
International journal of molecular sciences | 2016 |
Contribution of purinergic receptors to spinal cord injury repair: stem cell- based neuroregeneration
R Gomez-Villafuertes |
NEURAL REGEN RES | 2016 |
Stem cell therapy in spinal cord injury: Hollow promise or promising science?
A Goel |
Journal of Craniovertebral Junction and Spine | 2016 |
Current Concept of Stem Cell Therapy for Spinal Cord Injury: A Review
SK Oh, SR Jeon |
Korean Journal of Neurotrauma | 2016 |
Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation
MO Krucoff, S Rahimpour, MW Slutzky, VR Edgerton, DA Turner |
Frontiers in neuroscience | 2016 |